Myostatin in tendon maintenance and repair

References

• Amthor H, Christ B, Rashid-Doubell F, Kemp CF, Lang E, Patel K. Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev Biol 2002; 243(1)115–127
   PubMed Web of Science ®Google Scholar
• Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 2004; 270(1)19–30
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Forslund C. Enhanced tendon healing with GDF 5 and 6. Acta Orthop Scand 1999; 70(1)51–54
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Forslund C. Bone morphogenetic proteins and tendon repair. Scand J Med Sci Sports 2000; 10(6)372–375
   PubMed Web of Science ®Google Scholar
• Chang C, Hemmati-Brivanlou A. Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. Development 1999; 126(15)3347–3357
   PubMed Web of Science ®Google Scholar
• D'Souza D, Patel K. Involvement of long- and short-range signalling during early tendon development. Anat Embryol (Berl) 1999; 200(4)367–375
   PubMedGoogle Scholar
• Eliasson P, Fahlgren A, Aspenberg P. Mechanical load and BMP signaling during tendon repair: A role for follistatin?. Clin Orthop Relat Res 2008; 466(7)1592–1597
   PubMed Web of Science ®Google Scholar
• Forslund C, Aspenberg P. CDMP-2 induces bone or tendon-like tissue depending on mechanical stimulation. J Orthop Res 2002; 20(6)1170–1174
   PubMed Web of Science ®Google Scholar
• Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: Actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 2004; 127(2)239–254
   PubMed Web of Science ®Google Scholar
• Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 2002; 420(6916)636–642
   PubMed Web of Science ®Google Scholar
• Heinemeier KM, Olesen JL, Schjerling P, Haddad F, Langberg H, Baldwin KM, Kjaer M. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: Differential effects of specific contraction types. J Appl Physiol 2007; 102(2)573–581
   PubMed Web of Science ®Google Scholar
• Heinemeier KM, Olesen JL, Haddad F, Schjerling P, Baldwin KM, Kjaer M. Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J Appl Physiol 2009; 106(1)178–186
   PubMed Web of Science ®Google Scholar
• Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 1998; 95(16)9337–9342
   PubMed Web of Science ®Google Scholar
• Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 1998; 273(33)21145–21152
   PubMed Web of Science ®Google Scholar
• Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98(16)9306–9311
   PubMed Web of Science ®Google Scholar
• Lee KJ, Mendelsohn M, Jessell TM. Neuronal patterning by BMPs: A requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. Genes Dev 1998; 12(21)3394–3407
   PubMed Web of Science ®Google Scholar
• Lehmann K, Seemann P, Boergermann J, Morin G, Reif S, Knaus P, Mundlos S. A novel R486Q mutation in BMPR1B resulting in either a brachydactyly type C/symphalangism-like phenotype or brachydactyly type A2. Eur J Hum Genet 2006; 14(12)1248–1254
   PubMed Web of Science ®Google Scholar
• Li ZB, Kollias HD, Wagner KR. Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem 2008; 283(28)19731–19738
   Web of Science ®Google Scholar
• McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387(6628)83–90
   PubMed Web of Science ®Google Scholar
• Mendias CL, Bakhurin KI, Faulkner JA. Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA 2008; 105(1)388–393
   PubMed Web of Science ®Google Scholar
• Mikic B, Schalet BJ, Clark RT, Gaschen V, Hunziker EB. GDF-5 deficiency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 2001; 19(3)365–371
   PubMed Web of Science ®Google Scholar
• Mikic B, Bierwert L, Tsou D. Achilles tendon characterization in GDF-7 deficient mice. J Orthop Res 2006; 24(4)831–841
   PubMed Web of Science ®Google Scholar
• Mikic B, Entwistle R, Rossmeier K, Bierwert L. Effect of GDF-7 deficiency on tail tendon phenotype in mice. J Orthop Res 2008; 26(6)834–839
   PubMed Web of Science ®Google Scholar
• Philip B, Lu Z, Gao Y. Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 2005; 17(3)365–375
   PubMed Web of Science ®Google Scholar
• Reno C, Marchuk L, Sciore P, Frank CB, Hart DA. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques 1997; 22(6)1082–1086
   PubMed Web of Science ®Google Scholar
• Seemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K, Stricker S, Pohl J, Ploger F, Staub E, et al. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest 2005; 115(9)2373–2381
   PubMed Web of Science ®Google Scholar
• Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 2006; 147(7)3586–3597
   PubMed Web of Science ®Google Scholar
• Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 2000; 275(51)40235–40243
   PubMed Web of Science ®Google Scholar
• Zhu X, Topouzis S, Liang LF, Stotish RL. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 2004; 26(6)262–272
   PubMed Web of Science ®Google Scholar
• Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF, Huard J. Relationships between transforming growth factor-beta1, myostatin, and decorin: Implications for skeletal muscle fibrosis. J Biol Chem 2007; 282(35)25852–25863
   PubMed Web of Science ®Google Scholar